Concepta (LON:CPT)

Concepta (LON:CPT)


Share Price
3.32 p
Change
-0.18 (-5.14 %)
Market Cap
£8.80 m
Proactive Investors - Run By Investors For Investors

Concepta RNS Release

Director/PDMR Shareholding


RNS Number : 2286X
Concepta PLC
26 April 2019
 

 

26 April 2019

Concepta plc

Director/PDMR Shareholding

Following Admission of the new ordinary shares of 2.5p each ("Ordinary Shares") issued in the Placing announced on 8 April 2019, the directors shareholdings are as follows.

Name

Number of Shares acquired in the Placing

No of Ordinary Shares held

% of Ordinary Share Capital held

Matthew Walls (and connected parties)

1,000,000

1,525,000

0.58%

Adam Reynolds (and connected parties)

416,667

1,834,722

0.69%

Barbara Spurrier (and connected parties)

333,333

579,390

0.22%

Total voting rights

Following Admission, the Company's enlarged issued share capital will comprise 264,946,675 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of Ordinary Shares with voting rights will be 264,946,675. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries

Company: www.conceptaplc.com, Product: www.mylotus.com

Matthew Walls, Chairman

Tel: +44 (0) 1234 866601

 

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin

Tel: +44 (0)20 368 3550

Novum Securities

Colin Rowbury

+44 (0) 20 7399 9400

About Concepta plc:

Concepta plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus®, targeted at the personalised mobile health market with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant and to provide insight to unexplained infertility.

myLotus® is currently the only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception

rates and early diagnosis of fertility issues. The proposition of myLotus® is to empower women to better understand their hormone levels and menstrual cycle and help women conceive naturally by identifying their window of fertility and optimal time for conception.

The Company has received CE-mark certification for myLotus® and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2019.

myLotus® is expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to help them do so.

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details  of  th person  dischargin managerial  responsibilitie  person  closely associated

a)

Name

Matthew Walls

2

Reason for notification

a)

Position / status

Executive Chairman

b)

Initial notification

/Amendment

Initial

3

Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concepta plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument(ii) each type of transaction; (iii) each date; and (iv) each placwhere transactionhave been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Ordinary shares in Concepta plc

 

 

ISIN GB00BYZ2R301

 

 

Nature of the transaction

Subscription for 1,000,000 ordinary shares via a placing announced on 8 April 2019

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

     3.0 pence

1,000,000

 

d)

Aggregated information

n/a

e)

Date of the transaction

25 April 2019

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details  of  th person  dischargin managerial  responsibilitie  person  closely associated

a)

Name

Barbara Spurrier

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concepta plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument(ii) each type of transaction; (iii) each date; and (iv) each placwhere transactionhave been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Ordinary shares in Concepta plc

 

 

ISIN GB00BYZ2R301

 

 

Nature of the transaction

Subscription for 333,333 ordinary shares via a placing announced on 8 April 2019

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

     3.0 pence

333,333

 

d)

Aggregated information

n/a

e)

Date of the transaction

25 April 2019

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

 

1

Details  of  th person  dischargin managerial  responsibilitie  person  closely associated

a)

Name

Adam Reynolds

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer,  emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Concepta plc

b)

LEI

213800RBHY6LZDG13168

4

Details of the transaction(s): section to be repeated for (i) each type of instrument(ii) each type of transaction; (iii) each date; and (iv) each placwhere transactionhave been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Ordinary shares in Concepta plc

 

 

ISIN GB00BYZ2R301

 

 

Nature of the transaction

Subscription for 416,667 ordinary shares via a placing announced on 8 April 2019

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

     3.0 pence

416,667

 

d)

Aggregated information

n/a

e)

Date of the transaction

25 April 2019

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAPLKAFSNEEF

Concepta Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use